Sangamo Therapeutics, Inc.
B-CELL ENGINEERING
Last updated:
Abstract:
Described herein are constructs used for B-cell genomic engineering and for expression of a transgene and/or for modulation of B cell function.
Status:
Application
Type:
Utility
Filling date:
25 Jan 2018
Issue date:
21 Nov 2019